Full-time rheumatology clinicalfaculty at Regions Hospital,the VA Medical Center, andHCMC continue their tradition<strong>of</strong> excellence in patient careand teaching.This year, Barbara Segal, M.D.and her collaborators openeda <strong>University</strong> <strong>of</strong> <strong>Minnesota</strong>Scleroderma Specialty Clinic,which has already evaluatedover 50 new patients. Her goalin starting the Sclerodermaprogram at the <strong>University</strong> <strong>of</strong><strong>Minnesota</strong> has been two-fold:(1) to bring the medicalspecialists caring for sclerodermapatients together toallow for comprehensiveservices and maximum conveniencefor the patients and(2) to make available state<strong>of</strong>-the-artmanagement andaccess to the latest clinicalresearch. She has broughttogether a team <strong>of</strong> basic scientistsand clinical investigatorsto apply new insights into thegenetics <strong>of</strong> autoimmunity,pulmonary fibrosis, basicimmunology, and vascularbiology, with the aim <strong>of</strong>improving our understanding<strong>of</strong> the pathobiology <strong>of</strong> Sclerodermaand developing rationalinterventions. During thecoming year, they will beginenrolling patients in severalwell-designed randomizedprotocols for treatment <strong>of</strong>scleroderma disease manifestations(lung, skin, anddigital ulcers).Educational ProgramsIn addition to clinical service,this division is committed tothe education <strong>of</strong> the next generation<strong>of</strong> rheumatology careproviders and investigators.Medical students, internalmedicine interns, and residentsrotate through ourclinics, gaining experiencein the diagnosis and treatment<strong>of</strong> rheumatic diseases.The program, headed by AnneMinenko, M.D. at the <strong>University</strong>,includes (1) instructionin how to perform a detailedmusculoskeletal examinationusing patients from theMedical School’s standardizedpatient program, (2) instructionin how to perform jointaspirations and s<strong>of</strong>t tissueinjections using simulatedlimb models, and (3) selfguidedCD-ROM tutorials tocomplement the clinic andhospital learning experience.At Regions Hospital, ElieGertner, M.D. and EllenShammash, M.D. supervisethe instruction <strong>of</strong> medicalresidents and students onrheumatology clinical services.David Rhude, M.D. andPeter Schlesinger, M.D. directthe fourth-year medical studentrheumatology trainingat the HCMC. Rhude providesspecialized clinical trainingin the areas <strong>of</strong> metabolicbone disease and APS, whileSchlesinger focuses on thediagnosis and treatment <strong>of</strong>SLE and scleroderma. Theyboth participate in the clinicalcorrelations and physicalexamination skills components<strong>of</strong> the first-year medicalschool curriculum. At theVA Medical Center, MarenMahowald, M.D.; Hollis Krug,M.D.; and Jasvinder Singh,M.D. also provide importantmedical training opportunitiesto students and residents.In addition to training medicalstudents and residents,our ACGME-accredited twoyearrheumatology fellowshipprogram provides an intenseclinical training experiencefor physicians who desire acareer in specialized, state<strong>of</strong>-the-artrheumatology care.Our fellowship program currentlytrains two rheumatologyfellows at any given timeat both the UMMC and VAMedical Center sites underSegal’s direction. Clinicalresearch training opportunitiesfor fellows are now alsoavailable at HCMC. Finally, apersonalized scientific educationunder the tutorship <strong>of</strong>one <strong>of</strong> our research facultymentors provides M.D. andPh.D. post-doctoral fellows,as well as undergraduate andgraduate students, with anopportunity to contribute tothe search for a cure. Abundantfederal (NIH) fundingis available to support thisresearch training withinthe division.FacultyPr<strong>of</strong>essorsTimothy Behrens, M.D.Maren Mahowald, M.D. (VAMC)Ronald Messner, M.D.Daniel Mueller, M.D. (Director)Thomas Stillman, M.D. (HCMC)Elie Gertner, M.D. (Regions)Associate Pr<strong>of</strong>essorsHollis Krug, M.D. (VAMC)Barbara Segal, M.D.Assistant Pr<strong>of</strong>essorsThomas Bloss, M.D. (HCMC)Anne Minenko, M.D.Kathy Moser, Ph.D.Erik Peterson, M.D.David Rhude, M.D. (HCMC)Peter Schlesinger, M.D. (HCMC)Ellen Shammash, M.D. (Regions)Jasvinder Singh, M.D. M.P.H. (VAMC)Patricia Tam, Ph.D.instructorKeli Hippen, Ph.D.Faculty Honors andAwards for 2005Anne Minenko, M.D.American College <strong>of</strong> Rheumatology71
Division <strong>of</strong> Rheumatic and Autoimmune Diseases72Research ActivitiesAutoimmunity develops asthe consequence <strong>of</strong> a loss <strong>of</strong>tolerance to self-antigens.Investigations carried out byDr. Daniel Mueller are leadingto a better understanding<strong>of</strong> the biological and biochemicalnature <strong>of</strong> immuneself-tolerance. Of particularinterest are those factors (e.g.growth factors and costimulatoryligands) that determinewhether antigen stimulation<strong>of</strong> a T-cell will lead to anincrease in the clone size andthe development <strong>of</strong> protective(or pathological) effector function,or lead to its functionalinactivation (clonal anergy)and T-cell tolerance.Patty Tam, Ph.D. and RonaldMessner, M.D. are interestedin how viruses and their interactionwith the host affectthe development <strong>of</strong> chronicrheumatic and autoimmunediseases. Molecular analysis<strong>of</strong> coxsackievirus strains hasidentified the genetic determinantsthat cause chronicautoimmune myositis followinginfection. In a secondproject, second harmonic generationimaging technologythat is used to detect changesin diseased muscle is beingadapted to perform non-invasiveimaging <strong>of</strong> the collagenfound in knee joints. Thisproject represents an interdisciplinaryeffort headed byTam that includes investigatorsin dermatology, chemicalengineering, and materialsscience; the Biomedical ImageProcessing Laboratory; andphysics. The ability to detectminor degenerative changesin collagen on the cartilagesurface will translate into earlierdiagnosis and improvedopportunities for therapeuticintervention in joint diseasessuch as osteoarthritis.The Timothy Behrens Laboratoryis broadly interested inunderstanding the molecularbasis <strong>of</strong> human autoimmunediseases by engaging in alarge gene-mapping project inhuman SLE. In the past year,they demonstrated a geneticassociation <strong>of</strong> a polymorphism<strong>of</strong> the protein tyrosine phosphatasePTPN22 with humanSLE. The Behrens Laboratory,together with laboratories atNew York <strong>University</strong>/NorthShore and the <strong>University</strong> <strong>of</strong>California San Francisco,is working with familiesenriched for multiple differentautoimmune diseases.These families will be used toidentify genes that predisposeto autoimmunity in general.A second focus <strong>of</strong> the BehrensLaboratory is the use <strong>of</strong> mousemodels to better understandthe mechanism by which toleranceto self is maintained inthe immune system. Finally,the laboratory is using microarray technology to study bothpatients with autoimmunityand our various mouse modelsto identify novel moleculesand pathways that are dysregulatedin autoimmunity,so that improved therapies forpatients with autoimmune disorderscan be designed. Theirresults now suggest a criticalrole <strong>of</strong> interferon in the pathogenesis<strong>of</strong> human SLE.Erik Peterson, M.D. has developeda molecular immunologyresearch program thatis focused on the roles <strong>of</strong>T-cell signaling proteins inleukocyte development andautoimmunity. He has identifieda novel role for the leukocyte-specificadapter protein,ADAP, in the suppression <strong>of</strong>T-cell dependent autoimmunityin mice. His laboratoryis investigating the molecularand cellular bases for ADAPaction through studies <strong>of</strong> bothT-cells and <strong>of</strong> other ADAPexpressingleukocytes thatregulate T-cell activity in autoimmunedisease. Peterson hasalso discovered that anothernovel adapter protein, PRAM-1,is important for physiologicproduction <strong>of</strong> infection-fightingchemicals by neutrophils.Recent experiments suggestthat PRAM-1 interacts withprotein components <strong>of</strong> the cellular“trash disposal” system.Current studies are investigatingthe biologic significance<strong>of</strong> those interactions.A second group <strong>of</strong> projects inPeterson’s laboratory utilizesgene “knockout” technologyin mice to better understandthe cellular function <strong>of</strong>Lyp (PTPN22), the proteinphos-phatase recentlydescribed as a novel regulator<strong>of</strong> human SLE, rheumatoidarthritis, and autoimmunediabetes. Finally, in collaborationwith other faculty inthe Autoimmunity group atthe <strong>University</strong> and faculty atthe Mayo Clinic, Peterson islooking for clues to the pathogenesis<strong>of</strong> human psoriaticarthritis. He is using microarraytechnology to probe geneexpression pr<strong>of</strong>iles in peripheralblood <strong>of</strong> patients withthis disorder.Investigations by KathyMoser, Ph.D. are also focusingon the identification andcharacterization <strong>of</strong> genes thatlead to autoimmune processesin SLE, SS, and APS. Thesedisorders may overlap withinpatients, tend to cluster infamilies, and are thought toshare at least some aspects <strong>of</strong>immune dysfunction. Studies
- Page 2 and 3:
The University of Minnesota Departm
- Page 4 and 5:
of excellence and nationalprominenc
- Page 6 and 7:
The Division Heads haveagreed that
- Page 8 and 9:
Department of Medicine Educationfle
- Page 10 and 11:
Bradley benson, M.D.Medicine-Pediat
- Page 13 and 14:
UMPhysicians: Clinical Programsimpr
- Page 15:
Daniel Weisdorf, M.D.BMT Program Di
- Page 20 and 21:
Oncology Clinic, ImagingCenter, and
- Page 22 and 23: n Blue Cross and Blue Shieldof Minn
- Page 24 and 25: Affiliated Campus Reports23
- Page 26 and 27: FacultyThe core faculty is growingr
- Page 28 and 29: esidents and fulfilling itsbring in
- Page 30 and 31: tional cardiology. Dr. CrispinSemak
- Page 32 and 33: ClinicalOur outpatient services hav
- Page 34 and 35: VA Medical CenterThe Medicine Servi
- Page 36 and 37: Research funding in medicineservice
- Page 38 and 39: Divisions, Department of Medicine
- Page 40 and 41: in its earliest stages, beforeconve
- Page 42 and 43: with heart failure and otherforms o
- Page 44 and 45: pital is highly individual inits pa
- Page 46 and 47: Division of Gastroenterology, Hepat
- Page 48 and 49: From Left to Right: John R.Lake, MD
- Page 50 and 51: FacultyProfessorsHanna E. Bloomfiel
- Page 52 and 53: andomized, controlled trialof TU 02
- Page 54 and 55: Division of Geneticsactive collabor
- Page 56 and 57: Division of Hematology, Oncology, a
- Page 58 and 59: This UMPhysicians-ownedclinic house
- Page 60 and 61: Division of Infectious Diseases and
- Page 62 and 63: opment of invasive clinicalextraint
- Page 64 and 65: sleep medicine. Regions Hospitalpro
- Page 66 and 67: the clinical services to newsubgrou
- Page 68 and 69: Division of Renal Diseases and Hype
- Page 70 and 71: Faculty Honors andAwards for 2005in
- Page 74 and 75: in her lab rely on family-basedgene
- Page 76 and 77: Faculty Recognition: Fall 2005New D